Medical Mycology

Article	Citations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis	55
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	54
S5.1b Antifungal r esistance	54
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	40
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	40
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	39
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	36
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	34
P196 A rare presentation of subcutaneous Entomophthoramycosis	33
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	32
P361 Demystifying the NIH grant application process for international investigators	32
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	30
S1.3c Diversity and hybridization in Malassezia furfur	29
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	29
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories	29
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	27
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	26
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	26
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	24
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China	24
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	23
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	23
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	19
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	19
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	18

Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	18
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	17
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	17
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	17
P348 tRNA modifications in Candida virulence	16
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	16
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	16
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	16
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	15
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	15
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	15
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	14
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	14
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	14
S2.2a African histoplasmosis	14
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	14
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	14
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	13
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	13
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	13
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	13
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	13
S10.4c Successful treatment of mucormycosis in hematological diseases	13
P355 Pitfalls in medical mycology in India	13
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	12
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	12
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	12
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	12
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	12
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	12
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis	12
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	12
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	12
Antifungal efficacy of natural antiseptic products against Candida auris	11
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	11
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	11
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	11
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	11
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	11
Effects of the novel mitochondrial targeted compound phosundoxin against Sporothrix globosa : Microbial sensitivity test combined with transcriptomics an	11
P303 An unusual case of isolated gluteal abscess	11
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	11
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	10
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	10
Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients	10
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	10
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	10
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	10
P291 Aspergillosis: another force to reckon with during COVID-19 times	10
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	10

P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	10
Opaque cell-specific proteome ofCandida albicansATCC 10231	10
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	9
Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae	9
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	9
Predictors of Mortality in Individuals with Disseminated Histoplasmosis and Advanced HIV Disease	9
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	9
Whole genome characterization of Trichophyton indotineae isolated in Singapore	9
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	9
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	9
Lumbar puncture frequency and patient survival among persons hospitalized with cryptococcal meningitis in the United States	9
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	9
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	9
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	8
Risk factors for COVID-19 associated mucormycosis in India: A case control study	8
Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases	8
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	8
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	8
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	8
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	8
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	8
A practical approach to investigating nosocomial acquisition of Aspergillus	8
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	8
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	8
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	8
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles	8
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	8
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	8
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	8
S9.5c Malassezia-host interactions and the Il-23/17 axis	8
Comparison of three culture media for testing susceptibility of Malassezia pachydermatis to four antifungal agents by a microdilution method and gradient	7
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	7
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	7
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	7
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	7
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	7
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	7
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	7
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains	7
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	7
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	7
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	7
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	7
Thanks to Reviewers	7
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	7
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	7
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	7
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	7
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	7
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	7
P502 Mycology lab of the future—slants to sequencing	7
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	7
A notable azole-nonsusceptible Candida orthopsilosis in the Candida parapsilosis complex isolated from onychomycosis in Hue City, Central Vietnam	6
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	6
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	6
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	6
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections	6
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	6
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	6
The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis	6
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	6
P223 First case of Candida auris candidemia in Manipur, Northeast India	6
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	6
Value of qPCR in the screening strategy for Candida auris	6
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	6
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	6
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus	6
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	6
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	6
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	6
Exploring virulence attributes in non-Cryptococcus Tremellomycetes	6
Epidemiological shifts of invasive fungal infections in the current era of haematology	6
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	5
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	5
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	5
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	5
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	5
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	5
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	5
Cryptococcosis in domestic and wild animals: A review	5

Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	5
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	5
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	5
Octyl gallate as a treatment for Candida albicans-induced vaginal infection: Effects on fungal burden, inflammation, and Lactobacillus recovery in mice	5
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	5
Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patients	5
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	5
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	5
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	5
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	5
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia	5
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	5
Protoellisomyces batrachophilus , gen. et sp. nov., a novel member of the Mucor circinelloides complex causing mucormycosis in	5
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	5
Identification of potential targets in bone destruction by Talaromyces marneffei: Insights from data-independent acquisition proteomics	5
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	5
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	5
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	5
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with	5
Investigation of invasive fungal infection in tuberculosis/human immunodeficiency virus co-infected patients	5
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	4
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	4
Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus	4
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	4
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	4
A Falciformispora senegalensis grain model in Galleria mellonella larvae	4
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	4
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	4
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
Madurella mycetomatis grains within a eumycetoma lesion are clonal	4
Evaluation of simple molecular methods for distinction of the newly emerging dermatophyte Trichophyton indotineae	4
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	4
Interference of Malassezia restricta in the invasion of Staphylococcus aureus into human keratinocytes	4
P075 Initial results of an international effort in screening new agents against Candida auris	4
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	4
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	4
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	4
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	4
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study	4
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics	3
P259 Rare presentations of Cryptococcosis: a case series	3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	3
Identification of the cell-surface lectin domain-containing protein expressed in the adhesive colony morphology of Trichosporon asahii	3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)	3
Candida aurisfrom the Egyptian cobra: Role of snakes as potential reservoirs	3
Occupational non-invasive aspergillosis: a national multicenter retrospective study from the French National Network for Occupational and Environmental Disease Monitoring and Prevention (RNV3PE) 2001	3
P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india	3
P213 Lasiodiplodia theobromae: an emerging human pathogen	3
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris	3
Association of adverse effects with high serum posaconazole concentrations	3
S8.3b How fungal cell wall glycans modulate the activation of platelets ?	3
Clustered cases of Candida auris colonization: Roles of the infection prevention and control department and the mycology laboratory in controlling transmission	3
Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis	3
P204 Secondary organizing pneumonia caused by Aspergillus flavus in immunocompromised patients	3
P054 Two effects of curcumin to Candida albicans	3
P351 Genetic recombination between the main human skin commensal fungus, Malassezia restricta, and M. globosa using an Agrobacterium tumefaciens-mediated gene transfer system	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
Potential therapeutic targets for Cryptococcus	3
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa	3
Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques	3
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	3
P098 Human protothecosis: Acase report in Northeastern Brazil	3
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	3
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest	3
Molecular detection and species identification of dermatophytes by SYBR-Green real-time PCR in-house methodology using hair samples obtained from dogs and cats	3
S1.5b The burden of mycotic keratitis in West Africa	3
P178 An unusual recurrent case of Cryptococcal sacroilitis in an immunocompetent elderly female in Rajasthan, India	3
S8.2a Trends in epidemiology of pediatric Candida infections	3
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops	3
S6.4c Primary cutaneous implantation coccidioidomycosis	3
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization	3
P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive	3
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis	3
CAMEO – a Cross-Sectional Survey Study on Candidemia Management in Germany	3
Retracted: P495 Contamination of wind instruments: A potential threat to musicians	3
The need for fast and accurate detection of dermatomycosis	3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	3
Molecular epidemiology of seborrheic dermatitis/dandruff associated Malassezia species from northern India	3
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature	3
Detection of pan-azole resistant Aspergillus fumigatus in horticulture and a composting facility in Belgium	3
S8.3c Cell wall glycans as targets for the development of new antifungals	3
P468 Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park	3
P029 Synergic effect of deferoxamine combined with fluconazole against fluconazole-resistant Candida Spp. through inhibited Cek1 MAPK signaling pathway	3
P320 Ten cases of tinea incognito due to Trichophyton rubrum, and literature review on the pathogenic characteristics	3